Azerbaijan vs Cuba: Treatment success rate for patients treated for MDR-TB
Azerbaijan
67.0%
in 2022
Cuba
67.0%
in 2022
Azerbaijan rank
106th
Cuba rank
106th
Treatment success rate for patients treated for MDR-TB over time
- Azerbaijan
- Cuba
How they compare
Azerbaijan currently reports 67.0% against 67.0% in Cuba, a difference of 0.0%.
The two have swapped places 6 times across 15 shared years of data; in 2008 it was Cuba ahead.
Azerbaijan ranks 106th and Cuba ranks 106th of 163 countries.
Across the 3 decades both report, Azerbaijan averaged higher in 2 and Cuba in 1.
Head to head by decade
| Decade | Azerbaijan | Cuba | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 65.5% | 66.5% | 1.0% | Cuba |
| 2010s | 58.8% | 56.7% | 2.1% | Azerbaijan |
| 2020s | 64.3% | 58.0% | 6.3% | Azerbaijan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Azerbaijan or Cuba?
- Azerbaijan, at 67.0% against 67.0% in Cuba as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Azerbaijan and Cuba?
- 0.0%, with Azerbaijan ahead.
- How many years of comparable data are there for Azerbaijan and Cuba?
- 15 years are reported by both, from 2008 to 2022.
- How do Azerbaijan and Cuba rank globally for treatment success rate for patients treated for mdr-tb?
- Azerbaijan ranks 106th and Cuba ranks 106th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.